Early Notification Helping to Resolve Drug Shortages
This article was originally published in The Gold Sheet
Executive Summary
Despite a growing number of shortages, FDA has helped to prevent many more through its early notification program. An agency official predicted that shortages will be fewer this year thanks to combined FDA and industry efforts and intervention strategies.
You may also be interested in...
FDA Drug Shortage Advice: Talk To Us Early; We’ll Be Discreet
Manufacturers shouldn’t be afraid to work with FDA on preventing drug shortages for fear of public shaming, agency says.
FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin
The 11-member staff CDER devotes to drug shortages is moving to the Office of the Center Director and will report to Deputy Director for Regulatory Programs Doug Throckmorton.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.